Ankyrin repeat domain 26 pseudogene 4 (ANKRD26P4)

Ankyrin repeat domain 26 pseudogene 4 (ANKRD26P4) is classified as a human pseudogene, meaning it results from a duplication or mutation of a functional gene but is non-functional and does not produce a protein product[1][5]. Like other pseudogenes, ANKRD26P4 may share sequence similarity with the functional ANKRD26 gene, but it is typically not expressed or only transcribed at low levels; it lacks the regulatory or coding features needed for functional protein synthesis[1][5]. Although some pseudogenes have minor regulatory RNA roles or can contribute to gene regulation by acting as miRNA decoys or antisense transcripts, there is currently no evidence that ANKRD26P4 has specific biological or clinical relevance[2][5]. It is not a therapeutic target, does not interact with drugs, and is not used as a biomarker. Its significance is limited to bioinformatic annotation and potential interference in genetic studies (e.g., PCR bias)[5]. If you need information for the canonical functional gene (ANKRD26), note that ANKRD26 itself has some biological and clinical interest, but ANKRD26P4 is specifically a pseudogene and not a valid therapeutic target.

Other names

ANKRD26P4ankyrin repeat domain 26 pseudogene 4